Integrated Diagnostics Holdings plc
IDGXF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$341.24M
Close$
$1.44
146.1% upside
Current Fair Value
146.1% upsideUndervalued by 146.1% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $341.24 Million |
|---|---|
| Enterprise Value | $748.29 Million |
| Annual dividend | $0.03 |
| Dividend yield | 1.73% |
| Earnings per Share | $2.17 |
| Beta | 0.42 |
| Outstanding Shares | 581,326,272 |
Return
| Return on Equity | 38.51% |
|---|---|
| Return on Assets | 16.24% |
| Return on Invested Capital | 38.04% |
Valuation & Multiples
| P/E Ratio | 10.43 |
|---|---|
| PEG | 26.4 |
| Price to Sales | 0.04 |
| Price to Book Ratio | 0.07 |
| Enterprise Value to Revenue | 0.08 |
| Enterprise Value to EBIT | 0.3 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 2.75 |
| Debt to Equity | 0.52 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 11, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$76.52 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$75.01 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Integrated Diagnostics Holdings plc
6,309 employees
CEO: Hend El Sherbini
Integrated Diagnostics Holdings plc (IDGXF) functions as a consumer-focused healthcare enterprise, primarily dedicated to providing a comprehensive array of medical diagnostic services for patients. Its extensive service portfolio encomp...